← All trials
NCT07268053
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2026
- Primary completion
- Jul 31, 2027
- Completion date
- Jul 31, 2029
- First posted
- Dec 5, 2025
- Last posted
- Dec 5, 2025
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ArizonaLead sponsor
- GlaxoSmithKlineCollaborator
- Ivy Brain Tumor CenterOfficial
- University of ArizonaSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.